July to September 2007

London Genetics facilitates partnership between Oxford Gene Technology and Northwick Park Hospital

GE Healthcare launches IN Cell Analyzer Image Competition 2007: Win a trip to New York

Significant changes in store for growing HIV market

Pharmaceutical product lifecycle management technology gaining momentum

New treatments will drive fibromyalgia market forward

Targeted therapies promise new hope for brain cancer patients

Electronic prescribing: pharma seeks to maintain influence

Pandemic flu threat question remains unanswered

High Court's ruling on Alzheimer's drugs may have global implications for patient power

GlaxoSmithKline: Avandia to stay but damage is done

MERIT trial leaves role of Pfizer's Celsentri unclear

Novartis: underlining its strong position in the flu vaccine market

Generic erosion inevitable, but can be reduced

Changing of the guard in HIV treatment

RSV: lack of vaccine puts most vulnerable at risk

Need for new drugs to tackle 'superbugs'

IT in translational medicine: from data to drugs

Targanta Therapeutics: IPO based on oritavancin

New drug class to broaden treatment options for insomnia

Cardiovascular disease to become leading cause of death worldwide by 2020

Array BioPharma initiates clinical trials of cancer drug

Biogen and Vernalis start Parkinson's trial

FDA requests additional efficacy data for Dendreon's Provenge in advanced prostate cancer.

Bristol-Myers and Isis to collaborate on heart drugs

Meda and Ethypharm collaborate on NSAID

Breaking Merck patent may drive investment away from Brazil

Alkermes and Indevus start pulmonary disease study

Ranbaxy gets final authorization for generic Ambien

Pfizer's CCR5 inhibitor for HIV treatment has won backing from an FDA advisory panel.

Cerus considers immunotherapy spin off

Common pain medications do not prevent Alzheimer's disease

Senate bill pushing for government drug price negotiations is unlikely to save cash

Hormone therapy linked to increased incidence of ovarian cancer

Gemin X compound effective in leukemia

UCB epilepsy drug effective for pediatric patients

Schering-Plough receives Japanese approval for Zetia

Gilead reports positive data for cystic fibrosis antibiotic

Novoxel seeks to pre-empt MRSA drug concerns

Northbank Communications Joins College Hill

Future of Clinical Trials in Europe: Biotech industry's keys for change

IDBS and Titian to provide complete solution for drug discovery market

Nitec Pharma expands senior management team

Magnisense Strengthens Management Team with Technical Development Manager

Publication of key performance data for the CellMaker Lite2 with yeast cells (Pichia pastoris)

Launch of Flagship CellMaker PLUS™ - the World’s first dual-mode single-use bioreactor

Lab21 completes partnership deal with Monogram Biosciences to enable launch of HIV Trofile TM assay in UK

deltaDOT Ltd receives £3 million ($6.05 million) from investors

AUSTRIANOVA establishes Singapore subsidiary

Trophos Starts Phase Ib Clinical Trial of TRO19622 in Spinal Muscular Atrophy

CODEX paving the way for safety assessment of products with GM low level presence

Acrobot and Stanmore Implants announce computer assisted surgery collaboration

MorphoSys Granted Further U.S. Patent for its Core Antibody Technology HuCAL

Northbank Welcomes Back Dr Marc Egelhofer to London Team

Agilent Offers First FFPE Kit for Oligo CGH Microarrays

Agilent's Microarray Genomic Platforms Derive New Type of Mouse Embryonic Stem Cell

DBV Technologies and Numico (€2.6 billion of revenues in 2006) enter into an exclusive distribution agreement

ABLYNX IS AWARDED EUR 1.9 MILLION GRANT TO EXPLORE NEW THERAPEUTIC USES OF NANOBODIES

Amorphous and partially amorphous drug analysis and formulation takes centre stage through Synectix

PROIMMUNE LAUNCHES NEW MHC-PEPTIDE BINDING ASSAY FOR CLASS II HLA ALLELES

GATC Biotech announces collaboration agreement to develop comprehensive DNA-based sepsis diagnostic

Nitec's IND application for clinical development with Lodotra accepted by the FDA

Milestone reached as PANalytical celebrates 5th anniversary!

University of Surrey to use Cambridge Cell Networks' ToxWiz software to assist their research on Compound Safety Assessment.

GE Healthcare's IN Cell Analyzer Recognized with 2007 Frost & Sullivan Technology Innovation Award

Polyplus-transfection to Supply RNAi Therapeutic Delivery Technology to Alnylam Pharmaceuticals

Pharmaceutical Profiles IP confirmed on core company technology

MorphoSys Announces Clinical Milestone in Antibody Program

Experienced Stem Cell Industry Management Team Opens Doors to New Contract Services Business

AM-Pharma announces appointment of Chief Business Officer

DBV TECHNOLOGIES EXPANDS MANAGEMENT TEAM AND MOVES TO NEW FACILITIES IN PARIS

IntegraGen appoints Bernard Courtieu as CEO in a move to accelerate its commercial efforts

Scientific results presented at ICAAC demonstrate the well-differentiated profile and broad spectrum of BioAlliance Pharma's antifungal

Immutep Announces That ImmuFact(R) IMP321 Induces Activation of a Wide Range of Human Effector Cytotoxic Cells

Genmab expands use of IDBS’ ActivityBase Xtended Edition in Hybridoma Discovery

TTP LabTech’s European Roadshow - INNOVATIVE AUTOMATION ROADSHOW

BioAlliance Pharma Launches its First Product, Loramyc(R), on the French Market

BioAlliance Pharma Announces First Half 2007 Results

Trophos Closes EUR 8.5 Million in Series C Funding

Biocitech Technology Park Announces Oroxcell and Mutabilis

4th Annual Asia Pacific BioScience Forum, London, 11 October 2007

InferMed appoints Cancer Research UK's Dr Sally Burtles as Observer to the Board

OXFORD BIOMEDICA REACHES FIRST MILESTONE IN TROVAX COLLABORATION WITH SANOFI-AVENTIS

OXFORD BIOMEDICA PLC: INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2007

Acambis - FDA approves ACAM2000T vaccine for protection against smallpox

Meet the experts in San Diego - Pharmaceutical Profiles to host oral modified release formulations seminar

EDEN BIODESIGN AND BOREAN PHARMA APS SIGN DEAL TO DEVELOP NOVEL THERAPEUTIC CANDIDATE FOR THE TREATMENT OF CANCER

ALPHA BIOLOGICS PENANG MANUFACTURING FACILITY NEARS COMPLETION

New low-volume disposable cuvette extends protein analysis capabilities of the Zetasizer® Nano

New Chemiluminescent Application of G:BOX Image Analyzers

ProtAffin AG strengthens Scientific Advisory Board with two new appointments

Publication of key performance data for the CellMaker PLUS™ with CHO-S cells

Northbank picked to make the difference to BTG’s communications

European biotech industry releases policy on Biofuels in Europe

SOLVO Biotechnology has received the ISO 9001:2000 Quality Management System Certification

Antibiotics and Drug Resistance 2007 - New drug innovation and the strategy to combat antibiotic resistance mechanisms

Global cardiovascular drug market to hit $116.3billion by 2010 forecasts URCH Publishing

Molecular Partners Raises 18.5 Mio CHF (€11.28 million, $15.56 million) in Series A Financing

New syphilis test provides quicker and easier diagnosis

Synbiosis - Leading European Skin Disease Centre Uses ProtoCOL

Promotion and New Appointment in Northbank’s Congleton Office

London Genetics enhances its partnering capabilities by establishing a Scientific Advisory Board

Olympus introduces updated dotSlide virtual microscopy system: Virtual Slide: Real Analysis

Lab901 launches the ScreenTapeR system for rapid and fully automated gel electrophoresis

OXFORD BIOMEDICA ANNOUNCES DATA SAFETY MONITORING BOARD RECOMMENDATION TO CONTINUE TROVAX® PHASE III TRIAL IN RENAL CANCER AS PLANNED

SVS independently validates IDBS’ E-WorkBook Suite against 21 CFR Part 11 and GLP requirements

Simcyp strengthens its activities with the appointment of Professor Malcolm Rowland as Chairman of its Scientific Advisory Board

Dutch biotech AM-Pharma announces 2.5 Million Euro financing

Immunodiagnostic Systems Holdings PLC - Proposed acquisition of Biocode Hycel S.A.

Prosarix and ChemOvation enter into co-development and licensing agreement

TTP LabTech Announce US Expansion to Meet Growing Customer Demand

OXFORD BIOMEDICA: PUBLICATION OF TROVAX® PHASE II CLINICAL TRIAL DATA

Cambridge Healthcare & Biotech receives seal of approval for commitment to client focus and quality.

ACRUX ESTRADIOL SPRAY APPROVED BY FDA

Northbank Communications Strengthens Media Team with Promotion

Cobra Biomanufacturing Collaborates On Space Research

Acrobot secures £2.6 million investment in equity financing round

MARK T. CRANE, VICE PRESIDENT OF BUSINESS DEVELOPMENT AND MARKETING, BRINGS LEADERSHIP AND EXPERTISE FROM CAREER WITH TOP PHARMACEUTICAL SERVICE PROVIDERS

CERENIS THERAPEUTICS ANNOUNCES THE ADDITION OF THREE PHARMACEUTICAL INDUSTRY VETERANS TO ITS MANAGEMENT TEAM

Lectus Therapeutics strengthens management team and SAB

New DigiGenius Gel Documentation System Promises High Quality, yet Affordable Automated Imaging

Thrombotargets Corporation and Dr. Cam Patterson, Director of the Carolina Cardiovascular Biology Center at the University of North Carolina to create a Joint Venture for the exploitation of their proprietary technologies.

Thrombotargets Corporation announces the incorporation of Steven Hite as a Chief Operating Officer based in North Carolina, USA.

Thrombotargets Corp. and Magellan Bioscience Group, Inc. to collaborate on identification of novel hits from both marine derivate and natural products.

Thrombotargets Corp announced today that it has submitted its Orphan Drug Application of TT-103MH to the FDA for bleeding treatment in von Willebrand patients

Solvo Biotechnology Announces Appointment of Yuichi Sugiyama to the Scientific Advisory Board Budaörs, Hungary – July 20th, 2007

Astech launch new X-range of drug delivery automation products

Amsterdam Molecular Therapeutics raises additional €5.67 million in IPO following partial exercise over-allotment option

Virax HIV immunotherapeutic Phase IIa clinical trial results peer reviewed in Human Vaccines Journal

ClinTec International recruits Executive Vice President – Asia as part of a continued drive to evelop the Asian clinical research marketplace.

EuropaBio welcomes new EMEA technical document on biosimilars

Cancer Stem Cells Emerging Therapeutic Diagnostic and Market Opportunities

Secondary endpoints of phase II/III study confirm clear benefits from treatment with removab® for patients with malignant ascites

Acambis starts clinical testing of universal influenza vaccine

deltaDOT will play key analytical role in the US Defense Advanced Research Projects Agency (DARPA) drive to accelerate vaccine production

OXFORD GENE TECHNOLOGY APPOINTS DR TIM COOK TO THE BOARD

Australian drug delivery company Acrux delivers on male testosterone replacement lotion

IDBS Renews Participation in SAFE-BioPharma Association’s Vendor Partner Program

ProtoCOL Automated Colony Counter Is Helping Speed up Development of Novel Vaccine Technology

mtm laboratories announces new pivotal trial data resulting in European launch of the CINtecR Histology kit with extended clinical claims

BioInvent Interim Report

LifeCycle Pharma to Initiate Phase II Clinical Trial of LCP-AtorFen for the Treatment of High Cholesterol Levels

InferMed establishes Strategic Partnership with NNIT to host clinical trials Electronic Data Capture solution

Malvern Zetasizer Nano provides protein insight for both students and researchers at University of Massachusetts

Pronota awarded Euro 1.87M grant by Flanders Government to further develop its diagnostic biomarker discovery and validation platform

Can you get to once-a-day? Data-driven strategy rapidly achieves optimal oral drug delivery

AM-Pharma announces positive results of Phase IIa clinical trial with Alkaline Phosphatase for ulcerative colitis

Piramed Pharma wins Innovation in Drug Discovery & Development Award at the 2007 UKTI Bioentrepreneurial Company of the Year Awards

OXFORD GENE TECHNOLOGY LAUNCHES CYTOSURE PRODUCTS FOR THE CYTOGENETICS RESEARCH COMMUNITY

OXFORD BIOMEDICA SECURES RIGHTS TO ENDOSTATIN AND ANGIOSTATIN GENES FOR CANCER FROM CHILDREN'S HOSPITAL BOSTON

EMEA approves Kamada’s plans for phase II / III clinical trials of the aerosolized form of AAT for the treatment of Congenital Emphysema

BioInvent: Directed Issue approved at Extraordinary General Meeting

OXFORD GENE TECHNOLOGY GRANTS MICROARRAY LICENSE TO APPLIED MICROARRAY INC.

Santaris Pharma consortium awarded €1.35m by Denmark’s Advanced Technology Foundation for development of the first microRNA medicine

Malvern shows Zetasizer Nano new chromatography applications at Protein Society Meeting

Diatos Completes a Series D €9.4 Million Private Financing Round

amaxa to Co-ordinate Collaboration to Develop High-throughput Devices for Primary Cell Transfection

OXFORD BIOMEDICA AND SIGMA-ALDRICH ISSUE JOINT LICENCE FOR LENTIVECTOR TECHNOLOGY TO MAJOR BIOTECHNOLOGY COMPANY

 

---

April 2008

January to March 2008 Biotechnology News

January to March 2008 Biotechnology News

October to December 2007 Biotechnology News

July to September 2007

April to June 2007

January to March 2007

BioNewsCast Press Release Service 2006 Archive - January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ May 2006 ~ June 2006 ~ July 2006 ~ August 2006 ~ September 2006 ~ October 2006 ~ November - December 2006

BioNewsCast Press Release Service 2005 Archive - December 2005 ~ November 2005 ~ October 2005

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

---

Site Map - new news site

Site Map - old news site